Login

Geoff Jamieson, Managing Director of Orcoda Limited (ASX: ODA), discusses the partnership with ShareRing Australia Pty Ltd. 00:10:00

Share On Facebook Share On Twitter

Geoff Jamieson is Mng Dir/CEO at Orcoda Ltd.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:00:00
Professor Lindy Durrant, CEO, Scancell Holdings P
00:00:00
Ergomed announce £25mln acquisition - Miroslav Reljanović, CEO, Ergomed
00:10:00
Matts Johansen on Krill Fishing and Its Impact on Ocean Health | Matts Johansen, CEO, Aker BioMarine .
00:10:00
Bill Staples, CEO of New Relic, explains the importance of observability in managing modern infrastructure challenges.
00:10:00
Paving the Way: Primary Gold's Journey to Production
00:10:00
Aubrey McClendon, CEO of Chesapeake Energy Corp., discusses the potential of natural gas as an energy source.
00:10:00
Navigating Absolute Return in Crisis: Insights from Sébastien de Gendre on Resilient Investment Strategies | Sébastien de Gendre - Head of Absolute Return, CANDRIAM
00:10:00
CNX Resources Corp. Completes Spin-Off of CONSOL Energy | Nicholas J. DeIuliis, CEO, CNX Resources CorpCNX:NYQ
00:10:00
Shares the early influence and the core foundation of hard-working values|Andy Ziolkowski,Managing Partner,Cultivian Sandbox Ventures
00:10:00
ION Energy Eyes Strategic Growth and Exploration in 2024 Amid Lithium Market Recovery
00:10:00
Ridgeline Minerals: Nevada Gold Exploration
00:10:00
The CEO Outlook highlights that dotdigital Group Plc, a UK-based company, provides software as a service (SaaS) solutions, focusing on omnichannel marketing automation and customer engagement platforms​ |Milan Patel, CEO of Dotdigital

© 2017 - Neuhu+